omeprazole has been researched along with Laryngitis in 31 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Laryngitis: Inflammation of the LARYNGEAL MUCOSA, including the VOCAL CORDS. Laryngitis is characterized by irritation, edema, and reduced pliability of the mucosa leading to VOICE DISORDERS such as APHONIA and HOARSENESS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a population with laryngitis, the aim is to determine whether (a) omeprazole 20 mg tds (3 months) improves symptoms and laryngitis, and (b) the outcome in response to potent acid suppression can be predicted by esophageal and/or pharyngeal parameters during ambulatory pH monitoring or by other pretreatment variables." | 9.11 | Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis. ( Brake, HM; Cole, IE; Cook, IJ; Maclean, JC; Szczesniak, MM; Williams, RB, 2004) |
| "To evaluate the effect of omeprazole treatment on the symptoms and lesions of patients with posterior laryngitis (PL)." | 9.10 | Posterior laryngitis: effects of treatment with omeprazole alone. ( Argüelles-Arias, F; Carmona, I; Galera-Ruiz, H; Herrerías, JM; Muñoz-Borje, F; Rodríguez-Téllez, M, 2002) |
| " Both pantoprazole and placebo resulted in a marked improvement in laryngitis scores (decrease of 8." | 9.10 | Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. ( Eherer, AJ; Friedrich, G; Habermann, W; Hammer, HF; Kiesler, K; Krejs, GJ, 2003) |
| "Empirical treatment with lansoprazole is efficacious in relieving symptoms of laryngitis compared to placebo." | 9.09 | Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. ( Buchner, A; El-Serag, HB; Gavin, M; Inadomi, JM; Lee, P; McCarthy, DM, 2001) |
| "The signs and symptoms of posterior laryngitis improve with the administration of omeprazole and symptoms recur after discontinuation of therapy, suggesting that reflux is the underlying etiology." | 9.07 | Omeprazole for the treatment of posterior laryngitis. ( Hanson, D; Kahrilas, PJ; Kamel, PL, 1994) |
| "Our aims were to describe clinical characteristics of patients with chronic posterior laryngitis and to predict the response to omeprazole therapy." | 7.72 | Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice. ( Bastida, G; Bau, I; Garrigues, V; Gisbert, L; Nos, P; Ortiz, V; Ponce, J, 2003) |
| "Patients were evaluated with a history, physical examination, esophageal manometry, upper endoscopy, and 24-hour pH-metry for determination of the presence of absence of underlying gastroesophageal reflux disease and then received an empiric trial of oral omeprazole therapy (20 mg twice daily for 1 month)." | 7.69 | Pilot study of the oral omeprazole test for reflux laryngitis. ( Childs, ML; Metz, DC; Ruiz, C; Weinstein, GS, 1997) |
| "Empiric omeprazole therapy is a reasonable, initial approach to patients with suspected gastroesophageal reflux-related posterior laryngitis." | 7.69 | Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. ( Delgaudio, JM; Grist, WJ; Gussack, G; Waring, JP; Wo, JM, 1997) |
| "Laryngeal manifestations of gastroesophageal reflux disease are thought to be prevalent in our society." | 5.30 | Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole. ( Searl, JP; Shaw, GY, 1997) |
| "Gastroesophageal reflux disease (GERD) is known to cause a variety of symptoms that lead a patient to seek otolaryngologic care." | 5.29 | Gastroesophageal reflux laryngitis resistant to omeprazole therapy. ( Bough, ID; Castell, DO; Gideon, RM; Hills, JR; Sataloff, RT; Spiegel, JR, 1995) |
| "In a population with laryngitis, the aim is to determine whether (a) omeprazole 20 mg tds (3 months) improves symptoms and laryngitis, and (b) the outcome in response to potent acid suppression can be predicted by esophageal and/or pharyngeal parameters during ambulatory pH monitoring or by other pretreatment variables." | 5.11 | Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis. ( Brake, HM; Cole, IE; Cook, IJ; Maclean, JC; Szczesniak, MM; Williams, RB, 2004) |
| "To evaluate the effect of omeprazole treatment on the symptoms and lesions of patients with posterior laryngitis (PL)." | 5.10 | Posterior laryngitis: effects of treatment with omeprazole alone. ( Argüelles-Arias, F; Carmona, I; Galera-Ruiz, H; Herrerías, JM; Muñoz-Borje, F; Rodríguez-Téllez, M, 2002) |
| " Both pantoprazole and placebo resulted in a marked improvement in laryngitis scores (decrease of 8." | 5.10 | Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. ( Eherer, AJ; Friedrich, G; Habermann, W; Hammer, HF; Kiesler, K; Krejs, GJ, 2003) |
| "Empirical treatment with lansoprazole is efficacious in relieving symptoms of laryngitis compared to placebo." | 5.09 | Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. ( Buchner, A; El-Serag, HB; Gavin, M; Inadomi, JM; Lee, P; McCarthy, DM, 2001) |
| "The signs and symptoms of posterior laryngitis improve with the administration of omeprazole and symptoms recur after discontinuation of therapy, suggesting that reflux is the underlying etiology." | 5.07 | Omeprazole for the treatment of posterior laryngitis. ( Hanson, D; Kahrilas, PJ; Kamel, PL, 1994) |
| "Our aims were to describe clinical characteristics of patients with chronic posterior laryngitis and to predict the response to omeprazole therapy." | 3.72 | Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice. ( Bastida, G; Bau, I; Garrigues, V; Gisbert, L; Nos, P; Ortiz, V; Ponce, J, 2003) |
| " Patients with symptoms suspected to be due to laryngopharyngeal reflux (based on a positive oesophageal pH test and/or changes on videolaryngoscopy consistent with posterior laryngitis) were treated with omeprazole for at least two to three months." | 3.70 | Presumed laryngo-pharyngeal reflux: investigate or treat? ( Fraser, AG; Gillibrand, J; Morton, RP, 2000) |
| "Patients were evaluated with a history, physical examination, esophageal manometry, upper endoscopy, and 24-hour pH-metry for determination of the presence of absence of underlying gastroesophageal reflux disease and then received an empiric trial of oral omeprazole therapy (20 mg twice daily for 1 month)." | 3.69 | Pilot study of the oral omeprazole test for reflux laryngitis. ( Childs, ML; Metz, DC; Ruiz, C; Weinstein, GS, 1997) |
| "Sixteen patients who had symptoms and signs of chronic posterior laryngitis were evaluated before, during, and after treatment with omeprazole and nocturnal antireflux precautions." | 3.69 | Acoustic measurement of change in voice quality with treatment for chronic posterior laryngitis. ( Chen, J; Hanson, DG; Jiang, JJ; Pauloski, BR, 1997) |
| "Empiric omeprazole therapy is a reasonable, initial approach to patients with suspected gastroesophageal reflux-related posterior laryngitis." | 3.69 | Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. ( Delgaudio, JM; Grist, WJ; Gussack, G; Waring, JP; Wo, JM, 1997) |
| "Gastroesophageal reflux disease (GERD) often presents as typical symptoms such as heartburn or acid regurgitation." | 2.44 | [Extraesophageal manifestations of gastroesophageal reflux disease]. ( Kim, GH, 2008) |
| "Extraesophageal manifestations of gastroesophageal reflux disease (GERD) can include upper airway disorders, asthma and chronic cough." | 2.43 | Extraesophageal manifestations of GERD: diagnosis and therapy. ( Halstead, LA, 2005) |
| "Gastroesophageal reflux disease (GERD) is a common condition that effects about 10% of the adult population comprising a broad spectrum of symptoms and varying degrees of severity and frequency." | 2.42 | Extra-esophageal disorders in gastroesophageal reflux disease. ( Jaspersen, D, 2004) |
| "Gastroesophageal reflux (GER) is associated with a variety of laryngopharyngeal signs and symptoms." | 1.31 | Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux. ( Fuleihan, N; Hamdan, AL; Sharara, AI; Younes, A, 2001) |
| "The hallmark of GERD affecting the larynx in our group was posterior laryngitis, which is characterized by erythema of the mucous membrane overlying the arytenoid cartilages and the posterior mucosal wall of the glottis." | 1.31 | Laryngeal manifestations of gastroesophageal reflux disease in children. ( Blitek, A; Horobiowska, M; Iwanczak, B; Krecicki, T; Zalesska-Krecicka, M, 2002) |
| "Laryngeal manifestations of gastroesophageal reflux disease are thought to be prevalent in our society." | 1.30 | Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole. ( Searl, JP; Shaw, GY, 1997) |
| "The laryngitis was clinically and endoscopically unchanged in ten of the twelve (83." | 1.30 | [Is chronic laryngitis associated with Helicobacter pylori? Results of a prospective study]. ( Arps, H; Diehl, KL; Draf, W; Jaspersen, D; Kind, M; Weber, R, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (38.71) | 18.2507 |
| 2000's | 19 (61.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, GH | 1 |
| Rodríguez-Téllez, M | 1 |
| Galera-Ruiz, H | 1 |
| Argüelles-Arias, F | 1 |
| Carmona, I | 1 |
| Muñoz-Borje, F | 1 |
| Herrerías, JM | 1 |
| Siupsinskiene, N | 2 |
| Adamonis, K | 1 |
| Eherer, AJ | 1 |
| Habermann, W | 2 |
| Hammer, HF | 1 |
| Kiesler, K | 1 |
| Friedrich, G | 2 |
| Krejs, GJ | 1 |
| Garrigues, V | 1 |
| Gisbert, L | 1 |
| Bastida, G | 1 |
| Ortiz, V | 1 |
| Bau, I | 1 |
| Nos, P | 1 |
| Ponce, J | 1 |
| Williams, RB | 1 |
| Szczesniak, MM | 1 |
| Maclean, JC | 1 |
| Brake, HM | 1 |
| Cole, IE | 1 |
| Cook, IJ | 1 |
| Jaspersen, D | 4 |
| Kłopocka, M | 1 |
| Sinkiewicz, A | 1 |
| Budzyński, J | 1 |
| Pulkowski, G | 1 |
| Swiatkowski, M | 1 |
| Füessl, HS | 1 |
| Halstead, LA | 1 |
| Uloza, V | 1 |
| Pribuisiene, R | 1 |
| Butkus, E | 1 |
| Kupcinskas, L | 1 |
| Weber, R | 3 |
| Hammar, CH | 2 |
| Draf, W | 3 |
| Leite, LP | 1 |
| Johnston, BT | 1 |
| Castell, DO | 2 |
| Hanson, DG | 2 |
| Kamel, PL | 2 |
| Kahrilas, PJ | 2 |
| Bough, ID | 1 |
| Sataloff, RT | 1 |
| Hills, JR | 1 |
| Gideon, RM | 1 |
| Spiegel, JR | 1 |
| Hanson, D | 1 |
| Metz, DC | 1 |
| Childs, ML | 1 |
| Ruiz, C | 2 |
| Weinstein, GS | 1 |
| Jiang, JJ | 1 |
| Chen, J | 1 |
| Pauloski, BR | 1 |
| Shaw, GY | 1 |
| Searl, JP | 1 |
| Wo, JM | 1 |
| Grist, WJ | 1 |
| Gussack, G | 1 |
| Delgaudio, JM | 1 |
| Waring, JP | 1 |
| Diehl, KL | 1 |
| Kind, M | 1 |
| Arps, H | 1 |
| Rosenthal, DI | 1 |
| Eherer, A | 1 |
| Lindbichler, F | 1 |
| Raith, J | 1 |
| Pahn, J | 1 |
| Schlottmann, A | 1 |
| Witt, G | 1 |
| Wilke, W | 1 |
| Fraser, AG | 1 |
| Morton, RP | 1 |
| Gillibrand, J | 1 |
| El-Serag, HB | 1 |
| Lee, P | 1 |
| Buchner, A | 1 |
| Inadomi, JM | 1 |
| Gavin, M | 1 |
| McCarthy, DM | 1 |
| Hamdan, AL | 1 |
| Sharara, AI | 1 |
| Younes, A | 1 |
| Fuleihan, N | 1 |
| Noordzij, JP | 1 |
| Khidr, A | 1 |
| Evans, BA | 1 |
| Desper, E | 1 |
| Mittal, RK | 1 |
| Reibel, JF | 1 |
| Levine, PA | 1 |
| Zalesska-Krecicka, M | 1 |
| Krecicki, T | 1 |
| Iwanczak, B | 1 |
| Blitek, A | 1 |
| Horobiowska, M | 1 |
| Schade, G | 1 |
| Hess, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Placebo-Controlled Assessment of Lansoprazole 30 mg Bid in the Treatment of Gastroesophageal Reflux Associated With Laryngitis[NCT00369265] | Phase 4 | 18 participants (Actual) | Interventional | 2006-08-31 | Terminated (stopped due to Pharmaceutical company purchased by another company and funding was terminated.) | ||
| A Prospective Evaluation of the Utility, Optimal Cutoff and Positive Predictive Value of a Pharyngeal pH Probe for Predicting Proton Pump Inhibitor Response in Treatment Naive Laryngopharyngeal Reflux[NCT01755221] | 80 participants (Anticipated) | Interventional | 2012-08-31 | Active, not recruiting | |||
| Assessing the Impacts of an Upper Esophageal Sphincter Assist Device on Laryngeal Symptoms and Salivary Pepsin: A Pilot Study[NCT02552966] | 20 participants (Actual) | Interventional | 2015-09-01 | Completed | |||
| Post-nasal Drainage as an Extraesophageal Manifestation of Reflux[NCT00199953] | Phase 2 | 50 participants | Interventional | 2002-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
GERDQ score. Scale of 0-12, higher score indicates increased symptom severity. (NCT02552966)
Timeframe: 2 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| UESAD | 8.6 |
NGSSI questionnaire score (NCT02552966)
Timeframe: 2 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| UESAD | 26.8 |
Respiratory symptom index (RSI) score. Values between 0 and 45. Higher value is associated with increased symptom severity. (NCT02552966)
Timeframe: 2 weeks
| Intervention | units on a scale (Mean) |
|---|---|
| UESAD | 19.4 |
Average salivary pepsin concentration (NCT02552966)
Timeframe: 2 weeks
| Intervention | ng/mL (Mean) |
|---|---|
| UESAD | 158.4 |
4 reviews available for omeprazole and Laryngitis
| Article | Year |
|---|---|
[Extraesophageal manifestations of gastroesophageal reflux disease].
Topics: Anti-Ulcer Agents; Asthma; Cough; Esophageal pH Monitoring; Gastric Acidity Determination; Gastroeso | 2008 |
Extra-esophageal disorders in gastroesophageal reflux disease.
Topics: Asthma; Cough; Enzyme Inhibitors; Gastroesophageal Reflux; Humans; Laryngitis; Omeprazole; Proton Pu | 2004 |
Extraesophageal manifestations of GERD: diagnosis and therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; | 2005 |
[Modern attitude towards management of laryngopharyngeal form of gastroesophageal reflux disease. Lithuanian clinical practice guidelines for adults].
Topics: Adult; Algorithms; Antacids; Anti-Ulcer Agents; Domperidone; Dopamine Antagonists; Gastroesophageal | 2007 |
7 trials available for omeprazole and Laryngitis
| Article | Year |
|---|---|
Posterior laryngitis: effects of treatment with omeprazole alone.
Topics: Adult; Aged; Anti-Ulcer Agents; Female; Gastroesophageal Reflux; Humans; Laryngitis; Laryngoscopy; M | 2002 |
Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Cross-Over | 2003 |
Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Dose-Response Relationship, Drug; Drug Admi | 2004 |
Improvement in clinical course and laryngeal appearance in selected patients with chronic laryngitis after eight weeks of therapy with rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Benzimidazoles; Chronic Disease; Female; Human | 2004 |
Omeprazole for the treatment of posterior laryngitis.
Topics: Adult; Aged; Esophagitis; Female; Gastroesophageal Reflux; Humans; Laryngitis; Laryngoscopy; Male; M | 1994 |
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Chronic Disease; Double-Blind Method; Female; Gastroe | 2001 |
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Chronic Disease; Double-Blind Method; Female; Gastroe | 2001 |
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Chronic Disease; Double-Blind Method; Female; Gastroe | 2001 |
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Chronic Disease; Double-Blind Method; Female; Gastroe | 2001 |
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Chronic Disease; Double-Blind Method; Female; Gastroe | 2001 |
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Chronic Disease; Double-Blind Method; Female; Gastroe | 2001 |
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Chronic Disease; Double-Blind Method; Female; Gastroe | 2001 |
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Chronic Disease; Double-Blind Method; Female; Gastroe | 2001 |
Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Chronic Disease; Double-Blind Method; Female; Gastroe | 2001 |
Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.
Topics: Adult; Esophagitis, Peptic; Female; Gastric Acidity Determination; Humans; Laryngitis; Laryngoscopy; | 2001 |
20 other studies available for omeprazole and Laryngitis
| Article | Year |
|---|---|
Diagnostic test with omeprazole in patients with posterior laryngitis.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Diet; Endoscopy, Gastrointestinal; Esophagitis; Female; | 2003 |
Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Chronic Disease; Female; Gastroesophageal Reflux; Humans | 2003 |
[The best strategies against reflux disease. Acid stomach and the sequelae].
Topics: Anti-Ulcer Agents; Barrett Esophagus; Chest Pain; Esophagitis; Gastroesophageal Reflux; Helicobacter | 2004 |
[Association of gastroesophageal reflux and chronic laryngitis].
Topics: Adult; Aged; Anti-Ulcer Agents; Chronic Disease; Endoscopy, Digestive System; Female; Gastroesophage | 1995 |
Omeprazole for the treatment of posterior laryngitis.
Topics: Anti-Ulcer Agents; Drug Administration Schedule; Esophagus; Gastroesophageal Reflux; Humans; Hydroge | 1995 |
Outcomes of antireflux therapy for the treatment of chronic laryngitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chronic Disease; Famotidine; Female; Gastroesopha | 1995 |
Gastroesophageal reflux laryngitis resistant to omeprazole therapy.
Topics: Adult; Aged; Female; Gastroesophageal Reflux; Humans; Laryngitis; Male; Middle Aged; Omeprazole; Ret | 1995 |
Pilot study of the oral omeprazole test for reflux laryngitis.
Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Female; Gastroesophageal Reflux; Hu | 1997 |
Effect of omeprazole on the course of associated esophagitis and laryngitis.
Topics: Adult; Aged; Anti-Ulcer Agents; Chronic Disease; Esophagitis, Peptic; Esophagoscopy; Female; Follow- | 1996 |
Acoustic measurement of change in voice quality with treatment for chronic posterior laryngitis.
Topics: Adult; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Female; Gastric Acid; Hoarseness; Humans | 1997 |
Laryngeal manifestations of gastroesophageal reflux before and after treatment with omeprazole.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barium Sulfate; Contrast Media; Deglutition; Enzy | 1997 |
Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Topics: Anti-Ulcer Agents; Cough; Deglutition Disorders; Female; Follow-Up Studies; Gastroesophageal Reflux; | 1997 |
[Is chronic laryngitis associated with Helicobacter pylori? Results of a prospective study].
Topics: Adult; Aged; Anti-Ulcer Agents; Biopsy; Chronic Disease; Esophagitis, Peptic; Female; Follow-Up Stud | 1998 |
A case of reflux laryngitis controlled with proton pump blockade alone.
Topics: Adult; Anti-Ulcer Agents; Humans; Laryngitis; Male; Omeprazole; Proton Pump Inhibitors | 2000 |
Ex juvantibus approach for chronic posterior laryngitis: results of short-term pantoprazole therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chronic Disease; | 1999 |
[Diagnosis and therapy of laryngitis gastrica].
Topics: Adult; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Ga | 2000 |
Presumed laryngo-pharyngeal reflux: investigate or treat?
Topics: Anti-Ulcer Agents; Clinical Protocols; Diagnosis, Differential; Female; Gastroesophageal Reflux; Hum | 2000 |
Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cisapride; Gastroesophag | 2001 |
Laryngeal manifestations of gastroesophageal reflux disease in children.
Topics: Child; Enzyme Inhibitors; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Laryn | 2002 |
[Clinical management of reflux laryngitis].
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Diagnosis, Differential; Female; Gastroesophageal Reflux | 2002 |